A Comparison of Immune Reconstitution Following Human Placenta-Derived Stem Cells (HPDSC) with Umbilical Cord Blood Transplantation (UCBT) vs. UCBT Alone in Pediatric Recipients with Malignant and Non-Malignant Diseases

Authors

Sumeet Sandhu, New York Medical College
Allyson Flower, New York Medical CollegeFollow
Mark Geyer
Lauren Harrison, New York Medical CollegeFollow
Qiuhu Shi, New York Medical CollegeFollow
Michael Pulsipher
Roger Giller
Erin Morris
Liana Klejmont, New York Medical CollegeFollow
Janet Ayello, New York Medical CollegeFollow
Carmella van de Ven, New York Medical CollegeFollow
Xiaokui Zhang
Jodi Gurney
Lee Ann Baxter-Lowe
Mitchell Cairo, New York Medical CollegeFollow

Author Type(s)

Faculty, Resident/Fellow

Document Type

Abstract

Publication Date

4-2018

Journal Title

Journal of Clinical Immunology

Department

Pediatrics

Second Department

Health Behavior and Community Health

Third Department

Public Health

Recommended Citation

Sandhu, S., Flower, A., Geyer, M., Harrison, L., Shi, Q., Pulsipher, M., Giller, R., Morris, E., Klejmont, L., Ayello, J., van de Ven, C., Zhang, X., Gurney, J., Baxter-Lowe, L., & Cairo, M. (2018). A Comparison of Immune Reconstitution Following Human Placenta-Derived Stem Cells (HPDSC) with Umbilical Cord Blood Transplantation (UCBT) vs. UCBT Alone in Pediatric Recipients with Malignant and Non-Malignant Diseases. Journal of Clinical Immunology, 38 (3), 334-335. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/329